TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmarise Holdings Corp. ( (JP:2796) ) has issued an update.
Pharmarise Holdings Corporation reported a significant increase in net sales for the first nine months of the fiscal year ending May 31, 2025, with a 14.5% year-on-year growth. However, the company faced challenges with a substantial decline in operating profit and a net loss attributable to the owners, indicating potential operational difficulties. The financial results reflect a complex market environment, and the company has made changes in accounting policies and added a new company to its consolidation scope, which may impact future performance.
More about Pharmarise Holdings Corp.
Pharmarise Holdings Corporation operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is listed on the Tokyo Stock Exchange and aims to enhance its market presence through strategic initiatives.
YTD Price Performance: -8.70%
Average Trading Volume: 19,842
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen5.68B
For detailed information about 2796 stock, go to TipRanks’ Stock Analysis page.